MIMEDX GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.35 USD | -1.40% |
|
-7.97% | -27.59% |
| Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
| Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
Chart calendar MiMedx Group, Inc.
c68187155a1a54d.jntPlBOlcDVcanvMJuLAwla2_WqNPTKGJOlr46hUlO4.yT03_1TgKnJkMz-GaNe672XTuTvhUHnfRqw8jdgj45TkLzrDfJM-bwgnSw~c10d5003550c59d75cbe34629dc94a37
Upcoming events on MiMedx Group, Inc.
Past events on MiMedx Group, Inc.
| 2024-03-04 02:10 pm | TD Cowen Health Care Conference |
| 2024-02-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-28 04:01 pm | Q4 2023 Earnings Release |
| 2023-12-13 | Stifel MedTech West Coast Bus Tour |
| 2023-12-05 | Mizuho Medical Device and Healthcare Services Summit |
| 2023-11-15 | Craig-Hallum Alpha Select Conference |
| 2023-10-30 04:30 pm | Q3 2023 Earnings Call |
| 2023-10-30 04:01 pm | Q3 2023 Earnings Release |
| 2023-09-27 10:55 am | Cantor Global Healthcare Conference |
| 2023-09-18 | Northland Capital Markets Institutional Investor Conference |
| 2023-09-12 12:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-01 05:00 pm | Q2 2023 Earnings Call |
| 2023-08-01 04:01 pm | Q2 2023 Earnings Release |
| 2023-06-20 05:30 pm | Business Update Call |
| 2023-06-13 09:00 am | Annual General Meeting |
| 2023-05-02 05:00 pm | Q1 2023 Earnings Call |
| 2023-05-02 04:01 pm | Q1 2023 Earnings Release |
| 2023-02-28 05:00 pm | Q4 2022 Earnings Call |
| 2023-02-28 04:01 pm | Q4 2022 Earnings Release |
| 2022-11-30 09:30 am | Piper Sandler Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 248 242 2.71% | 259 255 1.46% | 268 268 -0.06% | 321 320 0.53% | 357 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 3,91 -5,20 175.27% | 58,5 55,1 6.14% | 73,3 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -45,4 -34,1 -33.12% | -5,04 -10,7 53.02% | -25,0 -28,7 13.06% | 55,1 24,1 128.32% | 53,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -61,5 -49,6 -24.04% | -10,0 -15,6 35.75% | -30,0 -33,6 10.64% | 30,6 17,6 74.29% | 53,0 |
|
Net income Million USD | Released Forecast Spread | -25,6 | -83,3 -38,4 -117.14% | -16,4 -19,0 13.41% | -36,8 -39,2 6.08% | 55,8 11,8 373.33% | 43,9 |
|
EPS USD | Released Forecast Spread | -0,24 | -0,77 -0,35 -120% | -0,15 -0,17 11.76% | -0,33 -0,33 1% | 0,37 0,10 260.98% | 0,31 |
| Announcement Date | 06/07/20 | 08/03/21 | 28/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 67,4 63,7 5.84% | 58,9 54,1 8.86% | 66,9 65,1 2.79% | 67,7 66,7 1.44% | 74,4 74,5 -0.21% | 71,7 64,2 11.73% | 81,3 74,8 8.6% | 81,7 77,9 4.84% | 86,8 85,2 1.98% | 79,4 | 89,0 | 91,5 | 97,3 | 87,5 |
|
EBITDA Million USD | Released Forecast Spread | -0,72 2,70 -126.81% | 7,32 -1,70 530.41% | 5,54 -1,32 518.66% | 14,1 5,80 143.14% | 17,6 14,7 20.17% | 21,2 17,9 18.75% | 13,7 | 18,5 | 19,0 | 21,7 | 15,5 | |||
|
EBIT Million USD | Released Forecast Spread | 3,30 -2,38 238.64% | -9,30 -9,75 4.62% | -9,64 -5,78 -66.6% | -7,10 -7,83 9.24% | 1,07 -2,67 140.21% | -3,38 -8,42 59.83% | 2,79 -0,15 1968.01% | 10,8 8,20 31.94% | 20,4 12,7 60.86% | 8,30 | 13,6 | 14,3 | 16,8 | 10,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,11 -3,48 160.58% | -10,4 -11,3 7.32% | -10,8 -6,61 -63.42% | -8,37 -8,69 3.6% | -0,38 -3,96 90.37% | -4,93 -9,79 49.63% | 1,13 -1,45 177.59% | 9,13 6,67 36.78% | 13,9 11,1 25.84% | 7,57 | 13,6 | 14,6 | 17,2 | 10,2 |
|
Net income Million USD | Released Forecast Spread | 0,62 -3,97 115.56% | -12,1 -11,3 -7.33% | -12,5 -8,51 -46.89% | -10,1 -9,99 -1.09% | -2,11 -6,13 65.58% | -6,67 -11,7 42.85% | -0,53 -3,42 84.56% | 6,76 5,77 17.24% | 44,8 9,44 374.71% | 6,30 | 11,3 | 11,9 | 14,4 | 7,60 |
|
EPS USD | Released Forecast Spread | 0,01 -0,03 130% | -0,11 -0,10 -10% | -0,11 -0,08 -46.67% | -0,09 -0,09 3.57% | -0,02 -0,05 62.5% | -0,06 -0,09 30.77% | 0,00 -0,03 - | 0,06 0,05 33.33% | 0,32 0,07 357.14% | 0,04 | 0,08 | 0,08 | 0,10 | 0,05 |
| Announcement Date | 28/02/22 | 03/05/22 | 02/08/22 | 02/11/22 | 28/02/23 | 02/05/23 | 01/08/23 | 30/10/23 | 28/02/24 | - | - | - | - | - |
Past sector events for MiMedx Group, Inc.
| 2024-02-28 04:01 pm | MIMEDX GROUP, INC.: Q4 2023 Earnings Release |
| 2023-10-30 04:01 pm | MIMEDX GROUP, INC.: Q3 2023 Earnings Release |
| 2023-08-01 04:01 pm | MIMEDX GROUP, INC.: Q2 2023 Earnings Release |
| 2023-05-02 04:01 pm | MIMEDX GROUP, INC.: Q1 2023 Earnings Release |
| 2023-02-28 04:01 pm | MIMEDX GROUP, INC.: Q4 2022 Earnings Release |
| 2022-11-02 04:15 pm | MIMEDX GROUP, INC.: Q3 2022 Earnings Release |
| 2022-08-02 04:05 pm | MIMEDX GROUP, INC.: Interim 2022 Earnings Release |
| 2022-05-03 04:31 pm | MIMEDX GROUP, INC.: Q1 2022 Earnings Release |
| 2022-02-28 04:06 pm | MIMEDX GROUP, INC.: FY 2021 Earnings Release |
| 2021-11-02 04:50 pm | MIMEDX GROUP, INC.: Q3 2021 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MDXG Stock
- Calendar MiMedx Group, Inc.
